324 filings
Page 4 of 17
8-K
phiqssk6yni
6 Nov 13
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results
12:00am
8-K
xgjy v70sdw0tdobs
23 Oct 13
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed In Phase 2A Cellulite Study of Collegenase Clostridium Histolyticum
12:00am
8-K
7tom0z2f6gzv5se
11 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
voh3rci7
7 Oct 13
Auxilium Pharmaceuticals, Inc. Presented Data at the Assh Annual Meeting About Xiaflex® for the Treatment of Dupuytren’s Contracture
12:00am
8-K
hne6cyu73c6lkjkam4i
3 Oct 13
Regulation FD Disclosure
12:00am
8-K
3hnmcrn
20 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
i95p46
28 Aug 13
Auxilium Receives Notification of Xiaflex® Pdufa Extension
12:00am
8-K
8etvtra62za0l9q
20 Aug 13
Other Events
12:00am
8-K
skioz2p4y2py7drycq
1 Aug 13
Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
12:00am
8-K
6sd r5ejl3va4bq
16 Jul 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
01kht591
12 Jul 13
With Report of Independent Auditors
12:00am
8-K
wpx hkcvnl8
13 Jun 13
Entry into a Material Definitive Agreement
12:00am
8-K
vw0cgd
11 Jun 13
National Survey Reveals Gaps in Perceptions and Realities of Living with Peyronie’s Disease, as Experienced by Both Men and Their Partners
12:00am
8-K
wep4v
29 May 13
Regulation FD Disclosure
12:00am
8-K
7p770row5mu6ppnc4t9
21 May 13
Regulation FD Disclosure
12:00am
8-K
1a2qs8
15 May 13
Regulation FD Disclosure
12:00am
8-K
30aqm1 w8s64lic5
6 May 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
d5v2v8jyhccpq7
29 Apr 13
Auxilium Pharmaceuticals, Inc, Announces First Quarter 2013 Financial Results
12:00am
8-K
c307a w46
3 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K
88zp2
1 Apr 13
Other Events
12:00am